MN
Maulish Nileshbhai Shah
About Maulish Nileshbhai Shah
Data last updated:
Maulish Nileshbhai Shah is a Director at Anabiosis Medsciences Private Limited (since 2020) and Director at Mermeds Lifesciences Private Limited (since 2021). The companies operate in Pharma and Life Sciences. The largest current company by reported revenue is Anabiosis Medsciences Private Limited at ₹21.84 Cr (FY 2025). Earlier, Maulish Nileshbhai Shah was a Designated Partner at Cybele Pharmalink Llp (from 2019) and Designated Partner at Remedio Life Science Llp (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Anabiosis Medsciences Private Limited U24230GJ2015PTC084113 | Director | 19 Dec 2020 | 2015 | ₹21.84 Cr (FY 2025) | Active |
| Mermeds Lifesciences Private Limited U24290GJ2021PTC126733 | Director | 26 Oct 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cybele Pharmalink Llp AAP-6484 | Designated Partner | 17 Jun 2019 | 2019 | Strike Off | |
| Remedio Life Science Llp AAZ-8620 | Designated Partner | 13 Dec 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Maulish Nileshbhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dishank Kanaiyalal Soni | 07211207 | Anabiosis Medsciences Private Limited | Director |
| Rajiv Rajendranath Bhargav | 03047185 | Anabiosis Medsciences Private Limited | Director |
| Varun Batra | 01980042 | Anabiosis Medsciences Private Limited | Additional Director |
| Viranchi Arvindbhai Shah | 01598001 | Mermeds Lifesciences Private Limited | Nominee Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maulish Nileshbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maulish Nileshbhai Shah
Maulish Nileshbhai Shah currently holds 2 directorships: Anabiosis Medsciences Private Limited (Director, since 19 Dec 2020, revenue ₹21.84 Cr (FY 2025)); Mermeds Lifesciences Private Limited (Director, since 26 Oct 2021).
Maulish Nileshbhai Shah was first appointed on 17 Jun 2019 as Designated Partner at Cybele Pharmalink Llp. The most recent appointment on record is 13 Dec 2021 at Remedio Life Science Llp.
Maulish Nileshbhai Shah held 2 earlier board appointments: Cybele Pharmalink Llp (Designated Partner, from 17 Jun 2019); Remedio Life Science Llp (Designated Partner, from 13 Dec 2021).
The current boards of Maulish Nileshbhai Shah's companies include Dishank Kanaiyalal Soni (Anabiosis Medsciences Private Limited), Rajiv Rajendranath Bhargav (Anabiosis Medsciences Private Limited), Varun Batra (Anabiosis Medsciences Private Limited), Viranchi Arvindbhai Shah (Mermeds Lifesciences Private Limited).